Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ischemic Cardiomyopathy: early-phase trial registry
5 of 11 indexed Ischemic Cardiomyopathy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 5 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Ischemic Cardiomyopathy: 11 US clinical trials tracked, 5 recruiting.
Ischemic Cardiomyopathy is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is State University of New York at Buffalo, running 2 of these trials.
Enrollment posture brief
Registry condition ischemic-cardiomyopathy
OPEN 5 | RECR 45% | LATE 0 | EARLY 3 | RANK #1577 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Breast Carcinoma (45% recruiting · 11 trials)
Ischemic Cardiomyopathy lists 5 open slots (45% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ischemic Cardiomyopathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ischemic Cardiomyopathy recruits in line with its size-band peers.
5 of 11 indexed trials (45.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Ischemic Cardiomyopathy research.
State University of New York at Buffalo accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Ischemic Cardiomyopathy enrolment sits around 257 participants.
Median target enrolment is 257 among the 11 trials that report a genuine target (sentinel values excluded). 2 of those (18.2%) plan for fewer than 100 participants.
-
Ischemic Cardiomyopathy splits between interventional and observational designs.
5 interventional and 6 observational studies make up this index (45.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Implantable Cardioverter Defibrillator (ICD Registry)
American College of Cardiology
NCT01999140
Left Ventricular Structural Predictors of Sudden Cardiac Death
Johns Hopkins University
NCT01076660
Phenotypic Classification of FMR With CMR
The Cleveland Clinic
NCT05965258
Venous Ethanol for Ventricular Tachycardia
The Methodist Hospital Research Institute
NCT05511246
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
Rush University Medical Center
NCT06138873
Prediction of ARrhythmic Events With Positron Emission Tomography II
State University of New York at Buffalo
NCT03493516
Assessment of Combined CCM and ICD Device in HFrEF
Impulse Dynamics
NCT05855135
Impella Supported OPCABG
Lucian Archambault Durham III
NCT04339452
Prediction of ARrhythmic Events With Positron Emission Tomography
State University of New York at Buffalo
NCT01400334
Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure
The University of Texas Health Science Center, Houston
NCT02501811
Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease
Stanford University
NCT01989195
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Ischemic Cardiomyopathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ischemic Cardiomyopathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ischemic Cardiomyopathy page
11 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Ischemic Cardiomyopathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- State University of New York at Buffalo sponsors the most Ischemic Cardiomyopathy trials on record, review their full trial history before evaluating a specific study. See State University of New York at Buffalo's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ischemic Cardiomyopathy condition card totals 11 registered trials; most-linked intervention 'seemore' - Manganese-enhanced MRI Contrast Reagent; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.